Option Care Health (NASDAQ:OPCH) Releases FY 2024 Earnings Guidance

Option Care Health (NASDAQ:OPCH) updated its FY 2024 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 1.550-1.590 for the period, compared to the consensus estimate of 1.210. The company issued revenue guidance of $5.0 billion-$5.0 billion, compared to the consensus revenue estimate of $4.9 billion. Option Care Health also updated its FY 2025 guidance to 1.590-1.690 EPS.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Barrington Research dropped their target price on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research report on Thursday, October 31st. Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their target price for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 target price (down from $31.00) on shares of Option Care Health in a research note on Friday. Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. Finally, Truist Financial cut their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $29.14.

Option Care Health Stock Up 9.8 %

Option Care Health stock traded up $2.36 during mid-day trading on Monday, reaching $26.35. The stock had a trading volume of 605,179 shares, compared to its average volume of 1,321,693. Option Care Health has a one year low of $21.39 and a one year high of $34.63. The company has a 50-day moving average price of $23.10 and a two-hundred day moving average price of $27.69. The company has a market capitalization of $4.48 billion, a price-to-earnings ratio of 22.14, a PEG ratio of 2.43 and a beta of 1.31. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the stock in a transaction on Friday, November 8th. The shares were acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the purchase, the director now owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.64% of the stock is currently owned by insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.